Anicca D. Harriot

Anicca D. Harriot

Auto-generated profile, based on publicly available information

Anicca D. Harriot

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Applied Physiology
Verified
Journal Article
Closed access
AHAnicca D. Harriot
Anicca D. Harriot
CWChristopher W. Ward
Christopher W. Ward
DKDeok-Ho Kim
Deok-Ho Kim
Microphysiological systems (MPS) or “organ-on-a-chip” models are sophisticated tools that harness techniques from cell biology, tissue engineering, and microengineering to recapitulate human physiology. Typically, MPS are biofabricated three-dimensional (3-D) tissue constructs integrated into platforms designed to mimic the tissue microenvironment and provide functional outputs. Over the past decade, researchers have endeavored to manufacture high-throughput, high-fidelity MPS models of all major human organs. By incorporating patient-derived cells, researchers have produced biomimetic models of tissues with disease-linked genetic mutations capable of exhibiting patient heterogeneity. This work has demonstrated that MPS more closely model organotypic function and pathophysiology than traditional two-dimensional (2-D) culture systems. Moreover, investigators have shown that human MPS are better predictors of drug efficacy and toxicity than animal models. Thus, MPS have emerged as a promising candidate to improve the efficacy and safety of preclinical trials. In this mini-review, we provide an overview of current advances in MPS models, their applications in mechanistic research, and relevance to drug screening. Finally, we discuss current investments in MPS development by the United States federal government and research institutions around the world to advance translational medicine.

21 January 2021 in Genealogy
Verified
Journal Article
Open access
PDF file
JIJedidah Isler
Jedidah Isler
NBNatasha Berryman
Natasha Berryman
AHAnicca Harriot
Anicca Harriot
CVChrystelle L Vilfranc
Chrystelle L Vilfranc
Léolène CarringtonLéolène Carrington
Léolène Carrington
DLDanielle Lee
Danielle Lee
#VanguardSTEM is an online community and platform that centers the experiences of women, girls, and non-binary people of color in science, technology, engineering, and mathematics (STEM) fields. We publish original and curated content, using cultural production, to include a multiplicity of identities as worthy of recognition and thus redefine STEM identity and belonging. #VanguardSTEM is rooted firmly in Queer, Black feminisms which delineate that the experiences and critiques of Black women matter and that these insights can foster a restorative and regenerative construction of the cultures in which we exist. In describing how #VanguardSTEM descended from counterspaces, we draw on speculative fiction to define a #VanguardSTEM hyperspace as a fluid “place-time” that is born digital and enabled by social media, but materializes in the physical world for specific purposes. As Black women in STEM, we consider how our situated knowledges and scientific expertise inform our process. We propose an intersectional scientific methodology to address the influence of embodied observation, embedded context and collective impact on scientific inquiry. Through #VanguardSTEM, we assert, without apology, the right of Black, Indigenous, women of color and non-binary people of color to self-advocate by fully representing ourselves and our STEM identities and interests, without assimilation.

13 September 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
ZRZhanping Ren
Zhanping Ren
AHAnicca D. Harriot
Anicca D. Harriot
DMDevin B. Mair
Devin B. Mair
MCMichael K. Chung
Michael K. Chung
PLPeter H. U. Lee
Peter H. U. Lee
DKDeok‐Ho Kim
Deok‐Ho Kim

29 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAnicca Harriot
Anicca Harriot
TATessa Altair-Morris
Tessa Altair-Morris
CVCamilo Venegas
Camilo Venegas
JKJacob Kallenbach
Jacob Kallenbach
KPKaylie Pinto
Kaylie Pinto
CWChristopher W. Ward
Christopher W. Ward
In Duchenne muscular dystrophy (DMD), alterations in the myofibrillar structure of skeletal muscle fibers that impair contractile function and increase injury susceptibility arise as a consequence of dystrophic pathology. In murine DMD ( mdx ), myofibrillar alterations are abundant in advanced pathology (>4 months), an age where we formerly established the densification of microtubules (MTs) post-translationally modified by detyrosination (deTyr-MTs) as a negative disease modifier. Given the essential role of MTs in myofibrillar growth, maintenance, and repair, we examined the increased abundance of deTyr-MTs as a potential mechanism for these myofibrillar alterations. Here we find increased levels of deTyr-MTs as an early event in dystrophic pathology (4 weeks) with no evidence of myofibrillar alterations. At 16 weeks, we show the level of deTyr-MTs is significantly increased and co-localized to areas of myofibrillar malformation. Profiling the enzyme complexes responsible for deTyr-tubulin, we identify vasohibin 2 (VASH2) and small vasohibin binding protein (SVBP) significantly elevated in the mdx muscle at 4 wks. We then use the genetic increase in VASH2/SVBP expression in 4 wk wild-type mice and find densified deTyr-MTs that co-segregate with myofibrillar malformations similar to those in the 16 wk mdx . Given that no changes were identified in fibers expressing EGFP as a control, we conclude that disease dependent densification of deTyr-MTs underscores the altered myofibrillar structure in dystrophic skeletal muscle fibers.